HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Yang Selected Research

2,6- dimethoxyhydroquinone- 3- mercaptoacetic acid

11/2001Synthesis of novel potential antitumor agents: 2,6-dimethoxyhydroquinone-3-mercapto-acetyl peptide conjugates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Yang Research Topics

Disease

35Neoplasms (Cancer)
01/2021 - 11/2000
12Lung Neoplasms (Lung Cancer)
12/2017 - 10/2001
8Infections
07/2021 - 07/2005
8Human Influenza (Influenza)
11/2018 - 02/2011
7Breast Neoplasms (Breast Cancer)
11/2020 - 03/2000
7Carcinogenesis
12/2017 - 07/2000
6Uveitis
02/2016 - 09/2000
6Inflammation (Inflammations)
02/2016 - 03/2000
5Pathologic Constriction (Stenosis)
09/2013 - 05/2000
4Insulin Resistance
03/2022 - 02/2008
4Asthma (Bronchial Asthma)
12/2021 - 02/2001
4Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
01/2020 - 09/2001
4Obesity
01/2019 - 02/2008
4Adenocarcinoma
01/2018 - 12/2002
4Autoimmune Diseases (Autoimmune Disease)
02/2013 - 02/2005
4Colorectal Neoplasms (Colorectal Cancer)
07/2012 - 07/2000
4Cardiovascular Diseases (Cardiovascular Disease)
01/2012 - 05/2000
4Hyperplasia
07/2010 - 11/2000
4Glaucoma
10/2003 - 11/2000
3COVID-19
04/2022 - 08/2021
3Ischemic Stroke
12/2020 - 04/2014
3Ischemia
01/2020 - 02/2001
3Shock
06/2019 - 05/2001
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 12/2015
3Atherosclerosis
01/2019 - 02/2010
3Hypoxia (Hypoxemia)
12/2015 - 05/2007
3Aneurysm (Aneurysms)
11/2015 - 05/2010
3Stomach Neoplasms (Stomach Cancer)
11/2015 - 04/2010
3Necrosis
10/2015 - 08/2014
3Fibrosis (Cirrhosis)
10/2015 - 12/2014
3Behcet Syndrome (Behcet's Syndrome)
05/2014 - 09/2001
3Hypersensitivity (Allergy)
02/2013 - 09/2011
3Body Weight (Weight, Body)
09/2009 - 10/2000
3Rheumatoid Arthritis
07/2001 - 05/2000
2Stroke (Strokes)
12/2020 - 01/2019
2Hepatocellular Carcinoma (Hepatoma)
08/2020 - 01/2009
2Reperfusion Injury
01/2020 - 10/2012
2Osteonecrosis (Kienbock's Disease)
11/2019 - 01/2001
2Heart Failure
06/2019 - 01/2017
2Myocardial Infarction
06/2019 - 05/2001
2Type 2 Diabetes Mellitus (MODY)
01/2019 - 04/2016
2Communicable Diseases (Infectious Diseases)
08/2018 - 02/2018
2Fatigue
01/2018 - 12/2014
2Disease Progression
01/2018 - 10/2012
2Prostatic Neoplasms (Prostate Cancer)
01/2018 - 07/2010
2Melanoma (Melanoma, Malignant)
01/2017 - 11/2000
2Adenocarcinoma of Lung
11/2016 - 07/2014
2Acute Liver Failure (Fulminant Hepatic Failure)
04/2016 - 01/2014
2Neoplasm Metastasis (Metastasis)
01/2016 - 01/2014
2Intracranial Aneurysm (Cerebral Aneurysm)
12/2015 - 11/2015
2Fever (Fevers)
02/2014 - 04/2002

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
11/2020 - 07/2000
7CytokinesIBA
01/2017 - 02/2001
6Messenger RNA (mRNA)IBA
12/2021 - 11/2000
6Pharmaceutical PreparationsIBA
12/2014 - 07/2000
6EnzymesIBA
01/2012 - 07/2000
5VaccinesIBA
06/2022 - 02/2011
5MicroRNAs (MicroRNA)IBA
12/2021 - 06/2011
5AntigensIBA
10/2018 - 09/2000
5DNA (Deoxyribonucleic Acid)IBA
12/2017 - 12/2001
4AllergensIBA
11/2020 - 02/2001
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2019 - 07/2015
4Influenza Vaccines (Influenza Vaccine)FDA Link
11/2018 - 02/2011
4SmokeIBA
12/2006 - 12/2002
3Nucleic AcidsIBA
04/2022 - 08/2018
3Biological ProductsIBA
11/2020 - 02/2005
3Long Noncoding RNAIBA
11/2020 - 08/2019
3LuciferasesIBA
10/2019 - 09/2014
3RNA (Ribonucleic Acid)IBA
08/2019 - 03/2000
3Phosphotransferases (Kinase)IBA
12/2017 - 07/2001
3CateninsIBA
01/2017 - 12/2014
3LipidsIBA
01/2017 - 09/2009
3LipopolysaccharidesIBA
04/2016 - 01/2014
3Transcription Factors (Transcription Factor)IBA
03/2016 - 04/2010
3Interleukin-6 (Interleukin 6)IBA
01/2015 - 04/2014
3InterleukinsIBA
08/2014 - 02/2011
3Biomarkers (Surrogate Marker)IBA
07/2014 - 11/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2001 - 05/2000
3omega-Chloroacetophenone (Mace)IBA
11/2000 - 05/2000
2Insulin (Novolin)FDA Link
03/2022 - 09/2009
2C-Reactive ProteinIBA
08/2020 - 01/2012
23' Untranslated Regions (3' UTR)IBA
10/2019 - 12/2015
2salicylhydroxamic acid (SHAM)IBA
06/2019 - 11/2015
2Therapeutic UsesIBA
06/2019 - 12/2018
2Phosphopyruvate Hydratase (Enolase)IBA
01/2018 - 05/2007
2tyrosine receptor (receptor, tyrosine)IBA
12/2017 - 01/2012
2AlbuminsIBA
08/2017 - 01/2017
2Interleukin-8 (Interleukin 8)IBA
01/2017 - 01/2015
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2016 - 12/2000
2Dinoprostone (PGE2)FDA Link
01/2016 - 10/2001
2Interleukin-10 (Interleukin 10)IBA
04/2014 - 02/2001

Therapy/Procedure

12Therapeutics
07/2021 - 04/2002
6Drug Therapy (Chemotherapy)
11/2020 - 05/2008
5Stents
12/2020 - 05/2000
3Length of Stay
10/2020 - 05/2001
3Contraindications
11/2018 - 08/2018
2Aftercare (After-Treatment)
07/2021 - 02/2014
2Immunotherapy
01/2021 - 11/2020
2Ligation
06/2019 - 11/2015
2Thrombectomy
01/2019 - 01/2017